C6 17
Alternative Names: C6-17; mAB C6 17Latest Information Update: 05 May 2021
At a glance
- Originator AFFiRiS
- Class Monoclonal antibodies
- Mechanism of Action HD protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Huntington's disease